Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GPR3 | P46089 | 1/20 | 0.37 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24735865 | 0.80 | IL1R1 (0.44) | KMT2ALMNASMN1; SMN2KDM4ERCE1 | |
| SCHEMBL26168251 | 0.78 | LMNA (0.44) | KMT2ALMNASMN1; SMN2KDM4EMAPT | |
| SCHEMBL26168119 | 0.78 | KMT2A (0.54) | KMT2ALMNASMN1; SMN2KDM4EATM | |
| SCHEMBL29634190 | 0.78 | KMT2A (0.54) | KMT2ALMNASMN1; SMN2KDM4EATM | |
| SCHEMBL3220620 | 0.77 | KDM4E (0.44) | LMNASMN1; SMN2KDM4EATMMAPT | |
| SCHEMBL26298538 | 0.77 | LMNA (0.43) | KMT2ALMNASMN1; SMN2KDM4EMAPT | |
| SCHEMBL18811821 | 0.76 | KDM4E (0.59) | KMT2ALMNASMN1; SMN2KDM4EATM | |
| SCHEMBL26169831 | 0.75 | GABRA1 (0.33) | LMNAALDH1A1GPR3 | |
| SCHEMBL6532206 | 0.73 | KDM4E (0.49) | KMT2ALMNASMN1; SMN2KDM4ERCE1 | |
| SCHEMBL26168244 | 0.73 | CA1 (0.42) | KMT2ALMNAKDM4EMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230276696-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2023-08-31 | — | — | US | disclosed |
| US-11678565-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11678565-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OPRD1 | KMT2A 4323/4885LMNA 782/4885SMN1; SMN2 4379/4885 |
| US-20230276696-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, PORCN | KMT2A 4003/4885LMNA 2148/4885SMN1; SMN2 4189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.